Exclusive: OxyContin maker Purdue Pharma exploring bankruptcy - sources

Indonesia Berita Berita

Exclusive: OxyContin maker Purdue Pharma exploring bankruptcy - sources
Indonesia Berita Terbaru,Indonesia Berita utama
  • 📰 Reuters
  • ⏱ Reading Time:
  • 20 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 11%
  • Publisher: 97%

EXCLUSIVE: Oxycontin maker Purdue Pharma exploring bankruptcy filing -sources

- OxyContin maker Purdue Pharma LP is exploring filing for bankruptcy to address potentially significant liabilities from thousands of lawsuits alleging the drug manufacturer contributed to the deadly opioid crisis sweeping the United States, people familiar with the matter said on Monday.

Purdue denies the allegations, arguing that the U.S. Food and Drug Administration-approved labels for its opioids carried warnings about the risk of abuse and misuse associated with the drugs. A Purdue bankruptcy filing is not certain, the sources said. The Stamford, Connecticut, drug maker has not made any final decisions and could instead continue fighting the lawsuits, they said.

Berita ini telah kami rangkum agar Anda dapat membacanya dengan cepat. Jika Anda tertarik dengan beritanya, Anda dapat membaca teks lengkapnya di sini. Baca lebih lajut:

Reuters /  🏆 2. in US

Indonesia Berita Terbaru, Indonesia Berita utama

Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.

Exclusive: OxyContin maker Purdue Pharma exploring bankruptcy - sourcesExclusive: OxyContin maker Purdue Pharma exploring bankruptcy - sourcesThe deliberations show how Purdue and its wealthy owners, the Sackler family, are under pressure to respond to mounting litigation accusing the pharmaceutical company of misleading doctors and patients about risks associated with prolonged use of its prescription opioids. Purdue denies the allegations
Baca lebih lajut »

Exclusive: OxyContin maker Purdue Pharma exploring bankruptcy - sourcesExclusive: OxyContin maker Purdue Pharma exploring bankruptcy - sourcesThe deliberations show how Purdue and its wealthy owners, the Sackler family, are under pressure to respond to mounting litigation accusing the pharmaceutical company of misleading doctors and patients about risks associated with prolonged use of its prescription opioids. Purdue denies the allegations
Baca lebih lajut »

Exclusive: Apollo bets on Clearway Energy, defying PG&E bankruptcy falloutExclusive: Apollo bets on Clearway Energy, defying PG&E bankruptcy falloutPrivate equity firm Apollo Global Management LLC has amassed a 6 percent stake i...
Baca lebih lajut »

Exclusive: Huawei plans billions in dividends for staff despite row with U.S. - sourcesExclusive: Huawei plans billions in dividends for staff despite row with U.S. - sourcesEXCLUSIVE: Huawei plans billions in dividends for staff despite row with U.S. - sources
Baca lebih lajut »

Exclusive: Brazil's state bank Caixa close to selling $2.4-billion Petrobras stake - sourcesBrazilian state-owned bank Caixa Economica Federal is close to selling a 9-billi...
Baca lebih lajut »

Exclusive: Exxon adds veteran traders to bulk up oil trading - sourcesExclusive: Exxon adds veteran traders to bulk up oil trading - sourcesExxon Mobil Corp has hired veteran crude traders Mitch Rubinstein and Michael Pa...
Baca lebih lajut »

Exclusive: KKR, China's Tencent eyeing bids for Universal Music - sourcesExclusive: KKR, China's Tencent eyeing bids for Universal Music - sourcesU.S. buyout fund KKR and China's Tencent Music Entertainment Group are expl...
Baca lebih lajut »

Exclusive: IMF agrees to extend Sri Lanka loan program, disburse delayed tranche - sourcesExclusive: IMF agrees to extend Sri Lanka loan program, disburse delayed tranche - sourcesThe International Monetary Fund has agreed to extend Sri Lanka's $1.5 billi...
Baca lebih lajut »

Opinion | The OxyContin catastrophe highlights a big failure in policyA Massachusetts lawsuit accuses Sackler family members of “illegal deceit” in the promotion of the opioid.
Baca lebih lajut »



Render Time: 2025-03-23 03:54:27